To investigate whether the effect of loureirin B plus capsaicin on tetrodotoxin-resistant (TTX-R) sodium channel.
RESULTS:
Loureirin B could not induce transient inward TRPV1 current. Capsazepine, a transient receptor potential vanilloid l (TRPV1) antagonist, could not attenuate the block of 0.64 mmol/L loureirin B on TTX-R sodium channel. There was no significant difference (P > 0.05) between IC50 of loureirin B (0.37 mmol/L) on TTX-R sodium channel in capsaicin-sensitive DRG neurons and that (0.38 mmol/L) in capsaicin-insensitive DRG neurons. However, there was a significant difference (P < 0.05) between the IC50 of capsaicin (0.28 μmol/L) on TTX-R sodium channel in capsaicin-sensitive DRG neurons and that (52.24 μmol/L) in capsaicin-insensitive DRG neurons. Four combinations composed of various concentrations of loureirin B and capsaicin could all inhibit TTX-R sodium currents but have different interactions between loureirin B and capsaicin.
CONCLUSION:
Loureirin B plus capsaicin could produce double blockage on TRPV1 and modulation on TTX-R sodium channel. The action of loureirin B on TTX-R sodium channel was independent of TRPV1 but similar with that of capsaicin on TTX-R sodium channel in capsaicin-insensitive DRG neurons.
INTRODUCTION
The red resin of Dracaena cochinchinensis (Lour.), called "dragon's blood" in China, is a kind of Traditional Chinese Medicines (TCM). Loureirin B, an active component of dragon's blood, was used as an index component to control and assess the quality of dragon's blood and its preparation. 1 In previous re-search, the modulation on the tetrodotoxin-resistant (TTX-R) sodium currents in dorsal root ganglion (DRG) neurons of loureirin B was demonstrated and this modulation was shown to be one of the pharmacological mechanisms of dragon's blood interfering with pain messages. [2] [3] [4] However, the mechanism of modulation on TTX-R sodium channel by loureirin B is unclear. In the following research, the modulation on capsaicin-induced transient receptor potential vanilloid 1 (TRPV1) currents of loureirin B was demonstrated. 5 TRPV1 is a non-selective cation channel. The properties of TRPV1 are consistent with early reports showing that capsaicin induces cation-selective inward currents and increases the intracellular free calcium concentrations ([Ca 2+ ]i) in a subset of DRG neurons. 6 Loureirin B at 4.9 μmol/L could reduce the inward currents activated by 1μmol/L capsaicin in DRG neurons by 50%. Similarly to capsaicin, loureirin B could evoke much slower and more stable elevation of [Ca In colon DRG cells that responded to capsaicin with an inward current, capsaicin virtually abolished voltage-gated sodium currents (VGSCs), and this effect was significantly attenuated by pretreatment with TRPV1 antagonist capsazepine. In capsaicin-sensitive trigeminal ganglion (TG) neurons, capsaicin (1 mmol/ L) inhibited VGSCs (mainly TTX-R sodium currents) by (71.0% ± 16.4%), and the inhibitory effects were also prevented by pretreating with capsazepine. 8 The modulation on VGSCs of capsaicin in high-level TRPV1-expressing neurons was mediated by activation of TRPV1. The capsaicin-induced activation of secondary messengers, such as cAMP, plays a part in this modulation. 9 The blocking effect of high concentrations of capsaicin on VGSCs in low-level TRPV1 expressing neurons shares many common characteristics with local anesthetics and amphiphiles. 10 Since there were significant similarities between loureirin B and capsaicin, two hypotheses can be put forward to explain the modulation mechanism on TTX-R sodium channel of loureirin B. First, loureirin B could induce the activation of TRPV1 and produce some secondary messengers that causes the modulation on TTX-R sodium channel in high-level TRPV1-expressing neurons. However, the combination of loureirin B and TRPV1 with high-affinity and low intrinsic activity leads to the attenuation of capsaicin-induced inward currents. Additionally, loureirin B, which could not induce the activation of TRPV1, could regulate VGSCs by altering lipid bilayer elasticity. The slow and stable elevation of [Ca 2 + ]i evoked by loureirin B was due to other mechanisms independent of TRPV1. To test the above hypotheses, the pharmacodynamic interaction between loureirin B and capsaicin was used as a novel tool to analyze the correlation of loureirin B modulating TTX-R sodium channel with capsaicin. In capsaicin-sensitive and capsaicin-insensitive DRG neurons, the modulations on TTX-R sodium currents induced by the combinations of loureirin B and capsaicin were observed. The synergistic and antagonistic interactions of the combinations were assessed using isobolograms. According to the interactions of the various combinations, the experiments about the contribution of loureirin B on the activation of TRPV1, the effects of capsazepine on loureirin B modulating TTX-R sodium channel, and the effects of loureirin B on lipid bilayer elasticity permeability were carried out. The results obtained may provide a reasonable explanation for the modulation mechanism on TTX-R sodium channel of loureirin B.
MATERIALS AND METHODS

Acute isolation of DRG neurons
One-month-old male or female Wistar rats (100-150 g) provided by Laboratory Animal Center, Wuhan Institute of Biological Products (Wuhan, China, Grade SPF, SCXK Hubei 2008-0003) were knocked out and decapitated. DRG was taken out and transferred immediately into 4 ℃ saturated Dulbecco's modified eagle medium (DMEM, Gibco, pH 7.4, NY, USA) solution gassed with 100% oxygen. The ganglion neurons were chopped and dissociated by collagenase 0.2 mg/mL (type Ⅰ, Sigma, CO, USA) and trypsin 0.1 mg/mL (Sigma, CO, USA) in a shaking bath (140 revolutions per min) for 15 min at 35 ℃ . Trypsin inhibitor at 0.3 mg/mL (Sigma, CO, USA) was added to stop the enzymatic digestion and then the cell suspension was filtrated through 200 mesh gauze into 35-mm culture dishes with bottom that had previously been paved with 5 mm × 5 mm microscopic glass coated with 1.0 mg/mL polylysine. The culture dishes were kept still to make the cells adhere to the microscopic glass. All the above steps were carried out at 25 ℃.
Whole-cell patch clamp recordings
An EPC-9 amplifier (HEKA, Lathbrecht, Germany) and the Pulse software (Version 8.5, HEKA, Lathbrecht, Germany) were used for whole-cell patch clamp recordings in voltage-clamp mode. Patch pipettes were fabricated with borosilicate glass capillary tubes (inner diameter 1.4 mm, Wuhan Weitan Technology Co., Ltd., Wuhan, China) on a 2-stage puller (PIP-5, HE-KA, Lathbrecht, Germany). Recording pipettes had resistances of 2-5 MΩ when filled with internal solution. A microscopic glass on which several DRG neurons attached, was placed in a special chamber (volume 0.5 mL) designed to perfuse external solution. DRG neurons (diameter approximately 20-35 μm) were selected for experiments because this type of cells is usually sensitive to capsaicin. 8, 11 After 1-5 GΩ seal formation be-tween a pipette and DRG membrane, the membrane was ruptured, and membrane capacitance was compensated. Then the whole-cell voltage-clamp configuration was obtained. Drug solution was delivered to the cell by using a rapid solution exchange system (DAD-12, ALA, NY, USA) and the distance from the mouth of tubule to the examined cell was less than 100 μm. Before the next recording, the residual drug was washed out with the external solution until the sodium currents recovered completely. The current responses mediated by TRPV1 in DRG neurons were evoked at a holding potential of -60 mV without any voltage stimulation under the mode of voltage clamp. At a holding potential of -80 mV, the TTX-R voltage-gated sodium currents were evoked by 50-ms duration depolarizing step pulses from -60 to + 30 mV with the step of 5 mV. The inactivation of TTX-R sodium currents was observed by using double pulse stimulation at a holding potential of -80 mV. The neurons were given a series of conditional voltage stimulations which were 50-ms duration depolarizing step pulses from -100 to -10 mV with the step of 10 mV, and each voltage stimulation was closely followed by a 50-ms duration depolarizing pulse to -10 mV test voltage stimulation.
Preparation of experimental drugs
The pipette solution contained (in mmol/L) 120 CsCl, 1 CaCl2, 5 MgCl2, 5 Na2ATP, 11 EGTA, 10 HEPES, 11 D-glucose, adjusted to pH 7.3 by 1 mol/L CsOH. The recording chamber had a volume of 350 μL, and it was perfused at a rate of 3 mL/min by external solution. External solution (a), which was used to record the current responses in DRG neurons induced by drugs, contained (in mmol/L) 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose, 10 HEPES. External solution (b), which was used to record TTX-R sodium currents, contained (in mmol/L) 30 NaCl, 90 Choline-Cl, 20 TEA-Cl, 5 CsCl, 2 CaCl2, 1 MgCl2, 20 D-glucose, 10 HEPES, 0.001 TTX. All external solutions were adjusted to pH 7.4 by 1 mol/L NaOH and osmosis pressures were approximately 300 mosM/L. CsCl, Na2ATP, EGTA, HEPES, CsOH, Choline-Cl, TEA-Cl, TTX were purchased from American Sigma Company. All other chemicals were of analytical grade unless otherwise stated. 
Statistical analysis
Using Pulse Fit software (version 8.5, HEKA, Lathbrecht, Germany) and Igor Pro software (version 4.09, WaveMetrics, OR, USA), patch clamp experimental data were analyzed. Data were expressed as the mean ± standard error of mean (SEM) and were analyzed statistically by one-way analysis of variance (ANOVA) and paired t-test was used to determine the statistical significance of differences between two sets of data. Comparisons between groups were tested by one-way ANOVA analysis and least significant difference test. A P < 0.05 was considered statistically significant. Percent inhibition rate on peak value of TTX-R sodium current produced by drug was calculated using Eq 1.
(1)
where I con tr ol and I drug are the peak values of TTX-R sodium currents in control and in the presence of drug respectively. Drug dose-response curve was fitted with Hill Eq 2.
Where Inhibition% is the percentage inhibition on peak values of TTX-R sodium currents produced by drug, Inhibitionmax% is the maximum of Inhibition% also called maximum efficacy. Here, the value of Inhibitionmax% was set at 1. c is the drug concentration, h is Hill coefficient and IC50 is the half maximal inhibitory concentration of the drug. Steady-state activation curve of TTX-R sodium currents was fitted with Boltzmann Eq 3.
where G is the sodium conductance calculated from the relationship
, I is the peak values of TTX-R sodium currents measured in given test potential, V m is the test potential, V rev is the reversal potential, G max is the maximum of the sodium conductance, K is the slope and V 0.5 is the half-activation potential.
Steady-state inactivation curve of TTX-R sodium currents was fitted with Boltzmann Eq 4.
where I is the peak values of TTX-R sodium currents measured in given test potential, I max is the maximum of I , V m is the corresponding conditional potential, K is the slope and V 0.5 is the half-inactivation potential.
Assessment of drug interaction
Two drugs that produce overtly similar effects will sometimes produce exaggerated or diminished effects when used concurrently. Thus, drug interactions are usually divided into the following three types: antagonism, synergism and additivity.
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A quantitative assessment is necessary to distinguish these cases from simple additive actions. The calculation is aided by a popular graph (isobologram) that provides a visual assessment of the interaction but also requires independent statistical analysis. 13 The latter can be accomplished from calculations that use the total dose in a fixed-ratio combination along with the calculated additive total dose for the same effect. When the dose-effect relations of the individual drug A and B have the same maxima (whether experimentally determined or obtained from curve fitting) and Hill coefficients, the potency ratio (R) is constant. That is, at every effect level, the ratio of dose A to dose B for the effect level is the same value R and the log dose-effect curves are parallel. In this case, the diagonal line connecting intercepts A and B is termed the additive isobole and is commonly expressed in Eq 5.
In this plot, each axis represents the dose of one of the drugs, and the intercept values represent the doses of the individual drugs that produce the specified effect E i (0 < E i < E max ). For drugs A and B, these doses are denoted here in Ai and Bi, respectively. All points (a, b) on this line segment represent dose pairs that give the specified effect. When both drugs could produce the maximal effects but are described by nonparallel log dose effect curves, the Hill coefficients that respectively describe their dose-effect relations are different. This is a situation of a variable potency ratio, but there is no obvious basis for distinguishing whether drug A is contributing to drug B or vice versa. The dose equivalence concept in this case leads to two different isoboles that are given by the pair of Eqs 6 and 7 below. The two isoboles result from effect Ei in which the individually effective doses are Ai and Bi. 15 The first by converting dose a into its equivalent of drug B to give Eq 6.
The second by converting dose b into its equivalent of drug A to give Eq 7.
where the meanings of a , b , A i , B i and those in Eq 5 are the same, A 50 and B 50 are the dose of drug A and B, respectively, that yield one-half individual maximal effect, p and q are the Hill coefficient describing the dose-response relation of drug A and B, respectively. When drug A (dose a' ) and drug B (dose b' ) resulting from the combined effect of effect E , the procedure of the assessment of drug interaction by using isobologramic analysis was given as follows. According to the case, the corresponding additivity isoboles for the combined effect E can be graphically shown in the isobologram. When the experimental point Q ( a' , b' ) is in the region bounded by the lower and upper additivity isoboles, the interaction between drug A and drug B is simply additive. When the point Q is below the region of additivity, such a departure from additivity is described here as synergism. In a similar manner, when the point Q is above the region of additivity, a departure from additivity is described here as antagonism.
RESULTS
Current response in DRG neurons induced by capsaicin and loureirin B
After stable GΩ seal formation, the holding potential was set to -60 mV without any voltage stimulation. To observe the current responses mediated by TRPV1 receptor in DRG neurons, 1 μmol/L capsaicin was delivered to DRG neuron 8 s. Next, 0.08, 0.16, 0.32, 0.64 mmol/L loureirin B were delivered to DRG neurons in the same way to observe whether loureirin B could activate TRPV1 receptor and produce current responses. When the induced current was greater than 100 pA, the neuron was deemed to have a current response to the drug. 9 Next, 10 μmol/L capsazepine was used to test whether the current responses were mediated by TRPV1 receptor. Before the injection of the next drug, the residual drug was washed out by 1 min perfusion with external solution. Of the 10 cells examined, 7 cells could be observed with enhanced inward current responses induced by capsaicin. Ten cells showed no current response with 0.08, 0.16, 0.32 and 0.64 mmol/L loureirin B (Figure 1 ).
Inhibition of A-803467 and lidocaine on TTX-R sodium currents in DRG neurons
With external solution (b), the holding potential was set to -80mV after stable GΩ seal formation, and then TTX-R sodium currents were evoked by 50-ms duration depolarizing step pulses from -60 to + 30 mV with a step of 5 mV. 0.03, 0.1, 0.3, 1 and 10 μmol/L A-803467 was delivered to DRG neurons to observe the TTX-R sodium currents before and after drug ad- Figure 2C ). Lidocaine at 0.1 mmol/L could change the half-inactivation potential of TTX-R sodium currents from -(44.83±2.96) to -(62.69±3.51) mV (P < 0.05) ( Figure 2D ). rents in capsaicin-sensitive DRG neurons were (10.9 ± 1.7), (24.8 ± 3.1), (39.1 ± 2.9) and (72.5 ± 4.6)% respectively. Inhibition rates of 0.08 and 0.16 mmol/L, 0.32 and 0.64 mmol/L loureirin B on TTX-R sodium currents in capsaicin-insensitive DRG neurons were (9.3 ± 1.3), (21.3 ± 3.3), (37.7 ± 3.9) and (74.7 ± 5.1)%, respectively. The concentration-response curves were also shown in Figure 3 . ANOVA test (influence factor was DRG neurons with or without capsaicin induced current responses) results showed that there was no significant difference in half inhibition concentration (IC50) of loureirin B on TTX-R sodium currents between capsaicin-sensitive and capsaicin-insensitive DRG neurons (P > 0.05).
Inhibition of loureirin B on TTX-R sodium currents in DRG neurons
After stable GΩ seal formation, the holding potential was set to -60 mV without any voltage stimulation. To observe the current responses mediated by TRPV1 receptor in DRG neurons, 1 μmol/L capsaicin was delivered to DRG neuron 8 s. Then the external solution (a)
Effect of capsazepine on loureirin B inhibiting TTX-R sodium currents in DRG neurons
After stable GΩ seal formation, the holding potential was set to -60 mV without any voltage stimulation. To observe the current responses mediated by TRPV1 receptor in DRG neurons, 1 μmol/L capsaicin was delivered to DRG neuron 8 s. Then the combination of 1 μmol/L capsaicin and 10 μmol/L capsazepine was used to test whether the current responses were blocked by capsazepine. Subsequently the external solution (a) was replaced by the external solution (b). At a holding potential of -80 mV, TTX-R sodium currents were evoked by 50-ms duration depolarizing step pulses from -60 to + 30 mV with the step of 5 mV. The combination of 0.64 mmol/L loureirin B and 10 μmol/L capsazepine was delivered to DRG neuron to observe the TTX-R sodium currents before and after drug administration. In 8 capsaicin-sensitive DRG neurons, the combination of loureirin B and capsazepine reduced TTX-R sodium currents by (71.9 ± 6.6)% (Figure 4) . ANOVA test results showed that capsazepine had no effect on the inhibition of loureirin B on TTX-R sodium currents (P > 0.05). Figure 5 ). ANOVA test (influence factor was DRG neurons with or without capsaicin induced current responses) results showed that there was a significant difference in half inhibition concentration (IC50) of capsaicin on TTX-R sodium currents between capsaicin-sensitive and capsaicin-insensitive DRG neurons (P < 0.05).
Inhibition of capsaicin on TTX-R sodium currents in DRG neurons
Combined effects of loueirin B and capsaicin on TTX-R sodium currents in DRG neurons
After stable GΩ seal formation, the holding potential was set to -60 mV without any voltage stimulation. To observe the current responses mediated by TRPV1 receptor in DRG neurons, 1 μmol/L capsaicin was delivered to DRG neuron 8 s. Then the external solution (a) was replaced by the external solution (b). In capsaicin-sensitive DRG neurons, combination Ⅰ (0.16 mmol/L loureirin B and 1 μmol/L capsaicin) and combination Ⅱ (0.32 mmol/L loureirin B and 1 μmol/L capsaicin) were delivered to DRG neuron to observe the activation and inactivation of TTX-R sodium currents before and after drug administration. In capsaicin-insensitive DRG neurons, combination Ⅲ (0.16 mmol/L loureirin B and 10 μmol/L capsaicin) and combination Ⅳ (0.32 mmol/L loureirin B and 10 μmol/L capsaicin) were delivered to DRG neuron in turn to observe the activation and inactivation of TTX-R sodium currents before and after drug administration.
Of the 20 cells examined, 12 cells could be observed with capsaicin-induced inward current responses. The inhibition rates of the combinations on TTX-R sodium currents were shown in Table 1 .
In capsaicin-sensitive DRG neurons, both combination Ⅰ and Ⅱ shifted the steady-state inactivation curves to hyperpolarization. The half inactivation voltage changed from -(42.4±1.3) to -(51.9±3.1) and -(47.9± 1.6) mV after combination Ⅰ and Ⅱ administration (P < 0.05), respectively. In capsaicin-insensitive DRG neurons, the half inactivation voltage in control was -(45.6 ± 2.3) mV. After combination Ⅲ and Ⅳ administration, the half inactivation voltage was -(46.9± 2.1) and -(47.3 ± 2.7) mV (P > 0.05), respectively ( Figure 6 ).
Assessment of interactions between loureirin B and capsaicin inhibiting TTX-R sodium currents
Since the inhibition of capsaicin on TTX-R sodium currents in capsaicin-sensitive DRG neurons was quite different from that in capsaicin-insensitive DRG neurons, the interaction between loureirin B and capsaicin inhibiting TTX-R sodium currents should also be di- vided into two cases. Whether in capsaicin-sensitive or in capsaicin-insensitive DRG neurons, it could be seen from their concentration-response curves that both the inhibition of loureirin B and capsaicin on TTX-R sodium currents can achieve the maximum efficiency of 1, but the Hill coefficients that describe their dose-effect relations were different. The assessment of the interactions between loureirin B and capsaicin inhibiting TTX-R sodium currents was carried out based on the additivity isoboles calculated by Eq 6 and 7 ( Figure 6 ). It can be seen from Figure 7A and 7B that when the combined effects were produced by loureirin B and 1 μmol/L capsaicin in capsaicin-sensitive DRG neurons, the coordinate values of points Q1 and Q2 were more than those of their corresponding theoretic additive points. Points Q1 and Q2 were respectively above the regions bounded by their corresponding additivity isoboles, which indicated that the combined effects produced by loureirin B and 1 μmol/L capsaicin in capsaicin-sensitive DRG neurons were antagonistic. However, it is difficult to see from Figure 7C and 7D that whether the points Q3 and Q4 were in the regions bounded by their corresponding additivity isoboles. The corresponding theoretic additive points of the point Q is the intersections of the additivity isoboles and the ray that starts at point (0, 0) and passes through point Q. As known from the calculation, 95% [8.81, 10.33] . Therefore when the combined effects were produced by loureirin B and 10 μmol/L capsaicin in capsaicin-insensitive DRG neurons, points Q3 and Q4 were in the regions bounded by their corresponding additivity isoboles, which indicated that the combined effect produced by loureirin B and 10 μmol/L capsaicin in capsaicin-insensitive DRG neurons was additive.
DISCUSSION
Loureirin B, a natural chemical component with analgesic activity, could be extracted from the flavonoids of traditional drug dragon's blood resin. 18 Capsaicin, the main capsaicinoid in chili peppers, is a homovanillic acid derivative. 19 We observed that loureirin B at low dose could inhibit TRPV1 currents induced by capsaicin. 5 These results are not surprising, given the structural similarity between loureirin B and capsaicin. However, no current response in DRG neurons was produced by loureirin B, which suggested that loureirin B may be the antagonist of TRPV1 but not agonist. Unlike capsaicin, the inhibition effects of loureirin B on TTX-R sodium currents had nothing to do with TRPV1. Capsazepine could not affect the inhibition of loureirin B on TTX-R sodium currents. There are strong indications that the inhibition mechanism of loureirin B on TTX-R sodium currents in capsaicin-sensitive DRG neurons was different from capsaicin. In capsaicin-sensitive and capsaicin-insensitive DRG neurons, the inhibition mechanisms of loureirin B on TTX-R sodium currents were the same. There was evidence that, non-selective effects of capsaicin on VGSCs in TRPV1−/− mice had similar characteristics and synergistic effects with local anesthetics. Similar mechanisms are supposed to underlie these effects. 20 The same is probably true of capsaicin and loureirin B. In capsaicin-insensitive DRG neurons, the combined effect produced by loureirin B and capsaicin was additive but not antagonistic. The modulated-receptor hypothesis about the mechanism by which local anesthetics and derivatives interact with VGSCs suggests that local anesthetic drugs bind more avidly to open and inactivated channels than to resting channels. Moreover, the binding site converts from a lowto high-affinity conformation during state transitions of the channels. 21, 22 The action of lidocaine on sodium channel gating charge results from allosteric coupling of the binding site(s) of lidocaine to the voltage sensors formed by the S4 segments in domains Ⅲ and Ⅳ. 23 As the positive control, lidocaine has an obvious effect on the inactivation curves of TTX-R sodium currents compared to A-803467. Consistent with our result, urethe combination of capsaicin and loureirin B can shift the steady-state inactivation curves of TTX-R sodium currents to hyperpolarization ( Figure 6 ). Moreover, our previous studies confirmed that 0.2 mmol/L loureirin B can cause the half inactivation potential of VGSCs shift in the hyperpolarizing direction. This improved inactivation and led to the accelerated inactivation phase. Accompanied with amplitude reduction, the voltage-dependent inactivation curve of TTX-R sodium currents shifted to hyperpolarizing direction, which also illustrated that loureirin B shared many common characteristics on the pharmacology mechanism with local anesthetics. In mammals, nociceptor terminals become insensitive to capsaicinand to other noxious stimuli with prolonged exposure. 24 This latter phenomenon of nociceptor desensitization underlies the seemingly paradoxical use of capsaicin as an analgesic agent in the treatment of painful disorders ranging from viral and diabetic neuropathies to rheumatoid arthritis. 25 In recent years, that capsaicin can affect the production of action potential by inhibiting the TTX-R sodium current in capsaicin-sensitive primary sensory neurons was also thought to be one of the causes of its analgesic effect. 8 However, hyperemia, mucous secretion, bronchoconstriction, breathing difficulties and other adverse reactions could be caused by the action of capsaicin on peripheral nerve endings and mucosa of skin. In addition, its clinical application was limited to a large extentbecause of the effects of capsaicin at high concentrations on the cardiovascular system, as well as on gastrointestinal and renal function. The main objective with capsaicin is to eliminate its adverse effect and retain its analgesic efficacy. Co-administration with other drugs, changing the drug delivery and choice of capsaicin derivatives are undoubtedly the most promising breakthroughs. 26 In capsaicin-sensitive DRG neurons, the combined inhibitory effects on TTX-R sodium currents produced by loureirin B and 1 μmol/L capsaicin were antagonistic. Inhibitory effects on TTX-R sodium currents produced by 1 μmol/L capsaicin alone were reduced by more than half. With the concentration of loureirin B increase in the combination, the effect of the combination on the inactivation of TTX-R sodium current also decreased, but the inhibition rate on the TTX-R sodium current was gradually increased. The results showed that loureirin B blocked the secondary messenger pathways necessary for capsaicin-dependent modulation on TTX-R sodium currents by inhibiting the activation of TRPV1. The inhibition of capsaicin on TTX-R sodium currents was weakened. Here, loureirin B produced the same antagonistic effect on TRPV1 as capsazepine. However, at the same time, the inhibition of loureirin B on TTX-R sodium currents was not affected by capsaicin. Whether in capsaicin-sensitive DRG neurons or in capsaicin-insensitive DRG neurons, the combination of loureirin B and capsaicin had a strong inhibitory effect on TTX-R sodium currents, blocking the activation of TRPV1 and eliminating part of the adverse effects of capsaicin. In conclusion, Loureirin B plus capsaicin could produce double blockage on TRPV1 and modulation on TTX-R sodium channel. The action of loureirin B on TTX-R sodium channel was independent of TRPV1 but similar with that of capsaicin on TTX-R sodium channel in capsaicin-insensitive DRG neurons.
